TORONTO, Aug. 13 /PRNewswire-FirstCall/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it will report its third quarter 2009 financial results on Monday, September 14, 2009.
Advertisement
In conjunction with this announcement, Patheon will host a conference call with financial analysts on Monday, September 14, 2009 at 10:00 a.m. (EDT) to discuss its third quarter 2009 financial results. The third quarter financial results news release will be issued at approximately 7:00 a.m. (EDT) on Monday, September 14, 2009.
Advertisement
Interested parties are invited to access the live call, via telephone, in listen-only mode, at 1-647-427-7450 (Toronto and International) or toll free at 1-888-231-8191 (U.S., including Puerto Rico). Listeners are encouraged to dial in five to fifteen minutes in advance to avoid delays. A live audio will also be available via the web at www.patheon.com. (Please note that Windows Media Player or RealPlayer is required.)
A telephone replay of the conference call will be available between Monday, September 14, 2009 and Monday, September 21, 2009 by calling 1-402-220-7738 or 1-888-562-2823 (toll free) and entering identification number 24957833, followed by the number key. The webcast will also be archived at www.patheon.com for three months.
ABOUT PATHEON
Patheon Inc. (TSX:PTI; www.patheon.com) is a leading provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, liquid-filled hard capsules and a variety of modified release technologies.
Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic(TM) programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API.
Patheon's integrated development and manufacturing network of 10 facilities, and 7 development centers across North America and Europe, strives to ensure that customer products can be launched with confidence anywhere in the world.
SOURCE Patheon Inc.
